Trifluridine/Tipiracil (TAS‐102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program

BACKGROUND. TAS‐102 is indicated for patients with metastatic colorectal cancer (mCRC) previously treated with, or not considered candidates for, available therapies. Given the complete inefficacy in half of patients, the lack of predictive factors, the palliative setting, and the financial and clin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Cremolini, Chiara, Rossini, Daniele, Martinelli, Erika, Pietrantonio, Filippo, Lonardi, Sara, Noventa, Silvia, Tamburini, Emiliano, Frassineti, Giovanni Luca, Mosconi, Stefania, Nichetti, Federico, Murgioni, Sabina, Troiani, Teresa, Borelli, Beatrice, Zucchelli, Gemma, Dal Maso, Alessandro, Sforza, Vincenzo, Masi, Gianluca, Antoniotti, Carlotta, Di Bartolomeo, Maria, Miceli, Rosalba, Ciardiello, Fortunato, Falcone, Alfredo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2018
Gaiak:
Gastrointestinal Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6263124/
https://ncbi.nlm.nih.gov/pubmed/29739893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0573
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak